VP Operations Non-clinical NHP development and CMC (Switzerland)

At FimmCyte Therapeutics, an innovative leader in biotech, we are seeking a dynamic and experienced Vice President of Operations focusing on advancing a novel molecule from development candidate to IND approval and beyond. Our company, with a close-knit team is committed to advancing cutting-edge therapeutics for large unmet needs. As VP of Operations, you will independently drive our endometriosis program through non-clinical development and CMC to ensure the successful progression towards the clinic. This position offers a unique opportunity to experience how a fast paced biotech operates with direct access to executives and the board. That in addition to the chance to drive the end-to-end development process of a novel molecule towards the clinic.

• Lead overall execution of advancing our antibody program from development candidate (DC) to IND approval
• Direct and oversee CMC, non-clinical safety, pharmacology, pharmacokinetics, and toxicology studies.
• Manage the budget and timelines
• Manage and build relationships with global CROs and CDMOs
• Ensure effective outsourcing strategies, vendor qualification, contract negotiations, and long-term partnerships.
• Interface with potential pharma partners to ensure the timely delivery of milestones
• Drive effective program timelines, resource allocation, and strong project management execution.
• Manage regulatory requirements in US, EU, and Australia

• Minimum 8 years of experience in project management in small to medium biotech or pharmaceutical organizations, >10 years preferred
• Minimum 5 years Experience in biologics non-clinical development and CMC
• Minimum 1 previous programs taken from DC to IND approval
• Proven experience managing CROs and CDMOs globally
• Strong project management background with demonstrated ability to deliver results on-time and within scope and budget.
• Strongly independent, can-do attitude, detail oriented, striving for maximum quality, speed and cost efficiency.
• Startup or small biotech experience is a strong plus
• Willing to travel 20% of the time globally
• Valid work authorization in Switzerland
• 100% Workload only
• January/2026 start

• Startup team with daily direct access to the executive team
• Competitive compensation with stock option plan
• Flexible working hours and location (Switzerland or Zurich/Basel)